“I Dream of an Ordinary Life”: Expanded Insurance Coverage Brings New Hope to Dravet Syndrome Families
“Until just before my daughter turned 2, she frequently suffered not only febrile seizures but also afebrile seizures.
Search results for "reimbursement"
South Korea’s First Homegrown CAR-T, Rimqarto, Moves Closer to Coverage with 67% Complete Response Rate
Curocell announced on Sept. 4 that its chimeric antigen receptor T-cell (CAR-T) therapy Rimqarto (generic name: anbalcabtagene autoleucel) was deemed...
South Korea Outlines National Health Insurance Coverage for Nursing Hospital Caregiver Costs
As part of a broader push to integrate caregiver costs into National Health Insurance, the Ministry of Health and...
Vabysmo Prefilled Syringe Gains Reimbursement, Expanding Retina Treatment Options
Injectable therapies for chronic eye diseases are entering a new era where clinicians and patients can select...
Supreme Court Ruling Ends 6.5-Year Battle Over Spinal Fusion Coverage for Osteoporosis Patients
In older adults with osteoporosis, performing spinal fixation surgery—inserting screws and rods to stabilize the spinal...
To Curb GLP-1 Misuse, Experts Urge Tracking Who Gets Prescribed Wegovy and Mounjaro—and Why
As the adoption of GLP-1 receptor agonist obesity medications such as Wegovy and Mounjaro accelerates, medical experts...
Over 65 and Shut Out of Stem Cell Transplants? Fitness, Not Age, Should Guide Multiple Myeloma Care
Older adults diagnosed with multiple myeloma should not automatically be ruled out for autologous hematopoietic stem...
Proposed Rule Change Could Give Northern Gyeonggi and Jeju Their First Top-Tier General Hospitals
Northern Gyeonggi Province and Jeju—currently the only medical service regions in South Korea without a single top-tier...
SK Plasma Launches High-Dose Revolpag 75 mg to Simplify Thrombocytopenia Regimens and Cut Costs
SK Plasma announced on Sept. 1 that it has begun distributing Revolpag Tablets 75 mg in South Korea, expanding its...
Zymfentra U.S. Sales Surge 176% as Celltrion’s Remsima Franchise Eyes 1 Trillion Won Annual Revenue
Biopharmaceutical company Celltrion announced on Aug. 27 that combined first-half sales of its subcutaneous infliximab...